Australian Research Institute IDs Novel Syndrome Variants with NextCODE Tools

June 23, 2014 | The ANZAC Research Institute in Sydney, Australia, has used NextCODE Health's Clinical Sequence Analyzer and Sequence Miner tools to ID novel sequence variants behind X-linked Charcot-Marie-Tooth syndrome (CMTX). "NextCODE's platform has enabled us to use whole-genome sequencing to identify variants never before linked to CMTX," said Dr Marina Kennerson, a principle research fellow at ANZAC in a NextCODE press release. The two tools are part of a suite of NextCODE offerings that were born from deCODE's data architecture. NextCODE Press Release